Suppr超能文献

研究游离碱和两种不同盐形式的溶解度及溶出度随pH的变化情况。

Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.

作者信息

Li Shoufeng, Wong SuiMing, Sethia Sundeep, Almoazen Hassan, Joshi Yatindra M, Serajuddin Abu T M

机构信息

Pharmaceutical and Analytical Development, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA.

出版信息

Pharm Res. 2005 Apr;22(4):628-35. doi: 10.1007/s11095-005-2504-z. Epub 2005 Apr 7.

Abstract

PURPOSE

To evaluate the effect of pH on solubility and dissolution rates of a model weak base, haloperidol, and two different salt forms, hydrochloride and mesylate.

METHODS

pH-solubility profiles were determined by using haloperidol base, haloperidol hydrochloride, and haloperidol mesylate as starting materials; concentrated or diluted HCl or NaOH solutions were added to aqueous suspensions of solids to adjust pH to desired values. Intrinsic dissolution rates were determined using intrinsic dissolution apparatus under various pH-stat conditions. Further, approximation of diffusion layer pH was estimated from that of 10% w/w slurries of drug substances in dissolution media, which were used to correlate with intrinsic dissolution rates of haloperidol and its salt forms under different pHs.

RESULTS

pH-solubility profiles of haloperidol base and its HCl salt were similar, while when the mesylate salt was used as starting material, it exhibited a higher solubility between pH 2 and 5. The higher solubility of the mesylate salt at pH 2-5 is attributed to its higher solubility product (K(sp)) than that of the hydrochloride salt. The pH-solubility profiles indicated a pH(max) (pH of maximum solubility) of approximately 5, indicating that the free base would exist as the solid phase above this pH and a salt would be formed below this pH. Below pH 1.5, all solubilities were comparable due to a conversion of haloperidol base or the mesylate salt to the HCl salt form when HCl was used as the acidifying agent. These were confirmed by monitoring the solid phase by differential scanning calorimeter. When their dissolution rates are tested, dissolution rates of the mesylate salt were much higher than those of the free base or the HCl salt, except at very low pH (<2). Dissolution rates of free base and HCl salt also differed from each other, where that of HCl salt exhibits higher dissolution rates at higher pHs. A direct correlation of dissolution rate with solubility at diffusion layer pH at the surface of dissolving solid was established for haloperidol, its hydrochloride, and mesylate salts.

CONCLUSIONS

Using pH-solubility and pH-dissolution rate interrelationships, it has been established that diffusion layer pH could be used to explain the observed rank order in dissolution rates for different salt forms. A non-hydrochloride salt, such as a mesylate salt, may provide advantages over a hydrochloride salt due to its high solubility and lack of common ion effect unless at very low pH.

摘要

目的

评估pH对模型弱碱氟哌啶醇及其两种不同盐形式(盐酸盐和甲磺酸盐)的溶解度和溶解速率的影响。

方法

以氟哌啶醇碱、氟哌啶醇盐酸盐和氟哌啶醇甲磺酸盐为起始原料测定pH-溶解度曲线;向固体水悬浮液中加入浓盐酸或氢氧化钠溶液或稀溶液,将pH调节至所需值。在各种pH-stat条件下,使用固有溶解装置测定固有溶解速率。此外,从溶解介质中10%w/w药物浆液的pH值估算扩散层pH值的近似值,用于关联不同pH值下氟哌啶醇及其盐形式的固有溶解速率。

结果

氟哌啶醇碱及其盐酸盐的pH-溶解度曲线相似,而以甲磺酸盐为起始原料时,在pH 2至5之间表现出更高的溶解度。甲磺酸盐在pH 2-5时较高的溶解度归因于其比盐酸盐更高的溶度积(K(sp))。pH-溶解度曲线表明最大溶解度pH值(pH(max))约为5,表明在此pH以上游离碱将以固相形式存在,在此pH以下将形成盐。在pH 1.5以下,由于使用盐酸作为酸化剂时氟哌啶醇碱或甲磺酸盐转化为盐酸盐形式,所有溶解度相当。通过差示扫描量热法监测固相证实了这些结果。当测试它们的溶解速率时,甲磺酸盐的溶解速率远高于游离碱或盐酸盐,但在非常低的pH(<2)时除外。游离碱和盐酸盐的溶解速率也彼此不同,其中盐酸盐在较高pH时表现出更高的溶解速率。建立了氟哌啶醇及其盐酸盐和甲磺酸盐在溶解固体表面扩散层pH值下溶解速率与溶解度的直接相关性。

结论

利用pH-溶解度和pH-溶解速率的相互关系,已确定扩散层pH值可用于解释不同盐形式观察到的溶解速率排序。非盐酸盐,如甲磺酸盐,由于其高溶解度和缺乏同离子效应,可能比盐酸盐具有优势,除非在非常低的pH值下。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验